Swine Flu Vaccine Additive Cripples Animals

Squalene - an additive proposed for possible use in swine flu vaccine - causes incurable diseases in animals.
By: www.without-consent.com
 
Sept. 29, 2009 - PRLog -- Without-Consent.com, a website informing the public about the toxicity of vaccine additives containing the oil squalene, releases its list of 30 peer-reviewed scientific papers showing the debilitating diseases induced in animals immunized with squalene. http://www.without-consent.com/media/SqualeneReferences-AnimalToxicology.pdf.  Withholding this information from volunteers enrolled in clinical trials testing swine flu vaccines containing this oil – and from the general public encouraged to consider vaccination with it should conditions warrant – violates informed consent standards upheld by the Nuremberg Code, the World Medical Assembly’s Declaration of Helsinki and the U.S. Department of Health and Human Services’ Rules and Regulations for the Protection of Human Research Subjects.  Squalene is an “adjuvant” – a substance used to accelerate and intensify the immune system’s response to weak vaccines.

Officials with the U.S. Department of Health and Human Services (HSS) and U.K. National Health Service (NHS) have argued for the possible inclusion of squalene adjuvants in candidate swine flu vaccines without informing the public that rats injected with squalene develop the animal versions of rheumatoid arthritis and multiple sclerosis; and induces antibodies specific to systemic lupus erythematosus in mice.  Rheumatoid arthritis, MS and lupus are incurable autoimmune diseases – diseases that occur when the immune system attacks the body it is supposed to defend.  Examination of rats injected with squalene showed severe inflammation in their joints; other show lesions in the brain and nerves stripped of their insulation called the myelin sheath.  Demyelization is a clinical hallmark of MS.  There are two squalene adjuvants being tested in clinical trials in the U.S. Europe, Asia and South America - MF59 from Novartis and AS03 from GlaxoSmithKline.  According to the manufacturers, at least 46 thousand volunteers are now enrolled in clinical trials for swine flu shots containing MF59 and AS03.  Novartis and GlaxoSmithKline say their adjuvants are safe.  The Novartis adjuvant, MF59, is already licensed in a seasonal influenza approved for human use in the European Union.  Around 40 million doses have been distributed in Europe safely, Novartis says.

WithoutConsent is an online information site created by Emmy Award-winning investigative journalist Gary Matsumoto who reported evidence of squalene-induced injuries to U.S. service personnel in Vanity Fair, and to both U.S. and British service members in his book Vaccine A.  He can be reached for comment at gary@without-consent.com, tel. 646.964.8646.  Further questions about squalene-induced autoimmunity can be sent to Dr. Robert F. Garry, Professor in Microbiology and Immunology at Tulane Medical School at rfgarry@tulane.edu; and Dr. Michael Whitehouse, Professor in Medicine at Griffiths University in Brisbane, Australia at whitehousemd@spin.net.au (Brisbane is EST +14 hours).  Queries about Vaccine A should be directed to Jocelyn Giannini, Assistant Marketing Manager, Basic Books, Basic Civitas, Nation Books, 387 Park Ave South New York, NY 10010; tel. 212.340.8143.

# # #

About WithoutConsent: WithoutConsent is a website about informed consent. We promote transparency in the pharmaceutical industry and the governments that regulate it ... because you can't make good choices with bad information - or no information at all.
End
Source:www.without-consent.com
Email:***@without-consent.com Email Verified
Zip:10024
Tags:Swine, Flu, Influenza, Adjuvant, Squalene, Autoimmune, Disease, Novartis, Glaxosmithkline, Arthritis, MS, Lupus, Trials
Industry:Medical, Health, Biotech
Location:New York City - New York - United States
Account Email Address Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share